Novo Nordisk president and CEO Lars Fruergaard Jørgensen joins CNBC's Sara Eisen to discuss the company’s latest trial results, how they fit into the weight-loss medicine landscape, and the supply-demand picture for Novo Nordisk’s products. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.
